Cigna names Brian C.
Filed with the SEC on · Summarized by InvestorsBot
Cigna names Brian C. Evanko CEO effective July 1, 2026; David M. Cordani will retire as CEO and become Executive Chair the same day. Evanko elected to the Board effective April 1, 2026; Board size increased to 12. $CI 👔🔁 #CEO #Succession #Healthcare
Evanko CEO comp (eff. July 1, 2026): base $1,300,000; EIP target $2,600,000; LTI target $15,100,000 (60% SPS, 25% restricted stock, 15% options). One‑time Transitional Equity Award: $3,500,000. $CI 💼💵 #Compensation #ExecPay
Cordani as Executive Chair (eff. July 1, 2026): base $1,000,000; EIP target $2,000,000; remains eligible for LTI. His 2026–28 SPS may vest after retirement if he stays in service 1 year from grant and meets covenants. Eric J. Foss named Lead Independent Director (Apr 1). $CI 🏛️ #Governance #Board